Yield10 Bioscience, Inc.  (MBLX)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 13
 Employees 68
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -8
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 0

Yield10 Bioscience, Inc.
Metabolix is an advanced biomaterials company focused on delivering sustainable solutions to the plastics industry. We have core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and we have assembled these capabilities in a way that has allowed us to integrate our biotechnology research with real world chemical engineering and industrial practice. In addition, we have created an extensive intellectual property portfolio to protect our innovations which, together with our technology, serves as a valuable foundation for our business.
Metabolix was formed to leverage the ability of natural systems to produce complex biopolymers from renewable resources. We have focused on a family of biopolymers found in nature called polyhydroxyalkanoates (“PHAs”), which occur naturally in living organisms and are chemically similar to polyesters. We have demonstrated the production of our PHAs from pilot to industrial scale and we have sold our PHA products commercially since 2012.
Our targeted markets offer substantial opportunity for innovation and value creation. Our strategy is based on the performance and differentiation of our materials. We aim to address unmet needs of our customers and leverage the distinctive properties of our proprietary PHA biopolymers to improve critical product qualities of material systems and enable our customers to enhance the value of their products and/or achieve cost savings through their value chains. As such, we are positioning our biopolymers as advanced specialty materials that offer a broad and attractive range of product and processing properties compared to other bioplastics or performance additives. We believe that a substantial global market opportunity exists to develop and commercialize our advanced biopolymer product technology.

   MBLX is expected to report next financial results on February 21, 2020.

Yield10 Bioscience's Segments
  Company Estimates  
  Revenue Outlook
Yield10 Bioscience does not provide revenue guidance.

Earnings Outlook
Yield10 Bioscience, Inc. does not provide earnings estimates.

Geographic Revenue Dispersion

Ieh Corp

Ieh Corp announced second quarter operating surplus of $2.042952 millions

For the second quarter income surged by 80 % to $0.54 per share, followed by Sales increase of 14.45 % to $7.55 millions, compared with the prior year period.

Abco Energy, Inc.

Losses Widen, Topline Tumbles

Abco Energy, Inc reported disastrous third quarter, where Sales faded by -53.66 % to $0.51 millions and loss per share has widen to $-0.01, from the same quarter a year ago.

Porter Holding International, Inc.

Break-even, Sales Faded

In the third quarter reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales crumbled by -30.53 % to $0.37 millions from $0.53 millions in the same quarter a year ago and sequentially Sales Tumbled by -62.7 % from $0.99 millions.

Oranco Inc

Oranco Inc announced first quarter operating income of $1.7380322685 millions

Sales for the first quarter increased by 7.12 % to $3.81 millions in comparison to $3.56 millions on a year-over-year basis, company posted earnings growth to $0.04, as comparison at $0.00 in the prior year quarter.

1847 Holdings Llc

Company Fail to Break-even Despite Surge in Sales

1847 Holdings Llc announced very strong Sales growth of 823.58 % year on year to $13.54 millions in the third quarter, but losses widen at $-0.25.

Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

WSTL's Profile

Stock Price

WSTL's Financials

Business Description


Charts & Quotes

WSTL's News


WSTL's Competitors

Customers & Markets

Economic Indicators

WSTL's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071